Found: 6
Select item for more details and to access through your institution.
Investigation of the Antiremodeling Effects of Losartan, Mirabegron and Their Combination on the Development of Doxorubicin-Induced Chronic Cardiotoxicity in a Rat Model.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 4, p. 2201, doi. 10.3390/ijms23042201
- By:
- Publication type:
- Article
Investigation of the Antihypertrophic and Antifibrotic Effects of Losartan in a Rat Model of Radiation-Induced Heart Disease.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 23, p. 12963, doi. 10.3390/ijms222312963
- By:
- Publication type:
- Article
Comparison of the antiremodeling effects of losartan and mirabegron in a rat model of uremic cardiomyopathy.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-96815-5
- By:
- Publication type:
- Article
Role of the kisspeptin-KISS1R axis in the pathogenesis of chronic kidney disease and uremic cardiomyopathy.
- Published in:
- GeroScience, 2024, v. 46, n. 2, p. 2463, doi. 10.1007/s11357-023-01017-8
- By:
- Publication type:
- Article
The kisspeptin-1 receptor antagonist peptide-234 aggravates uremic cardiomyopathy in a rat model.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-41037-0
- By:
- Publication type:
- Article
The kisspeptin-1 receptor antagonist peptide-234 aggravates uremic cardiomyopathy in a rat model.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-41037-0
- By:
- Publication type:
- Article